Bone development in patients with spinal muscular atrophy (SMA)

Universitätsmedizin Göttingen0 个研究点目标入组 400 人开始时间: 2018年9月25日最近更新: 2026年8月3日

适应症

干预措施

试验速览

阶段: 不适用
状态: 招募中
发起方: Universitätsmedizin Göttingen
入组人数: 400

研究概览入排标准研究组 & 干预措施研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Observational

入排标准

年龄范围: 5 Years 至 17 Years（—）
性别: All

入选标准

•Following appropriate counseling and informed consent, the study will include all children and adolescents between the ages of 5 and 17 with a spinal deformity and SMA or another underlying condition who are undergoing surgical correction in the Department of Pediatric Orthopedics at UMG.

排除标准

•Patients who do not meet the criteria listed above or who do not consent to participate in the study are excluded.

研究组 & 干预措施

Group 1: For patients with SMA undergoing spinal fusion surgery, the bone and cartilage tissue obtained during the procedure, as well as blood, urine, and sputum samples, will be analyzed; in addition, patient data and clinical X-ray, MRI, and CT images (which are routinely obtained for the surgeries) will be evaluated.

干预措施: Group 1: For patients with SMA undergoing spinal fusion surgery, the bone and cartilage tissue obtained during the procedure, as well as blood, urine, and sputum samples, will be analyzed; in addition, patient data and clinical X-ray, MRI, and CT images (which are routinely obtained for the surgeries) will be evaluated.

研究者

发起方

Universitätsmedizin Göttingen

相似试验

招募中

不适用

An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)Spinal Muscular Atrophy (SMA)

NCT07543003University of Oxford90

已完成

不适用

Effects of Developmental Support for Mothers of Infants With Spinal Muscular AtrophyDevelopmental DelaySpinal Muscular Atrophy

NCT07547189Medipol University8

进行中（未招募）

1 期

ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical TrialsMedDRA version: 20.1Level: PTClassification code: 10041582Term: Spinal muscular atrophy Class: 100000004850Spinal Muscular Atrophy

CTIS2024-511707-42-00ovartis Pharma AG160

尚未招募

3 期

ong-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 in Clinical trialsSpinal Muscular Atrophy

JPRN-jRCT2033230642Hirano Takamitsu4

招募中

不适用

Long-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 in Clinical trialsSpinal Muscular Atrophy

jRCT2033230642Novartis Pharma. K.K.4